Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

Expert Ratings for SMART Glb Hldgs

SMART Glb Hldgs (NASDAQ:SGH) has observed the following analyst ratings within the last quarter:

Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $3,000 Today

Microchip Technology (NASDAQ:MCHP) has outperformed the market over the past 15 years by 1.51% on an annualized basis producing an average annual return of 7.64%. Currently, Microchip Technology has a market capitalization of $31.64 billion.

Benzinga

Ominous Death Cross Forms On Mondelez International's Chart

If history is any guide, there may be trouble ahead for shares of Mondelez International (NASDAQ:MDLZ). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Expert Ratings for TaskUs

Analysts have provided the following ratings for TaskUs (NASDAQ:TASK) within the last quarter:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022

Upgrades

Benzinga

$100 Invested In Marriott Intl 15 Years Ago Would Be Worth This Much Today

Marriott Intl (NASDAQ:MAR) has outperformed the market over the past 15 years by 1.08% on an annualized basis producing an average annual return of 7.23%. Currently, Marriott Intl has a market capitalization of $43.93 billion.

Benzinga

Akerna Stock Plummets Following $10M Public Offering

Akerna Corp. (NASDAQ: KERN) announced the pricing of an underwritten public offering of 29.38 million units of the company consisting of 29.38 million shares of common stock together with common stock warran

Benzinga

Read news from The Economist, FT, and more,
with one subscription

PetVivo Holdings's Return On Capital Employed Overview

Benzinga Pro data, PetVivo Holdings (NASDAQ:PETV) reported Q4 sales of $55.46 thousand. Earnings fell to a loss of $1.78 million, resulting in a 8.2% decrease from last quarter.

Benzinga

AMMO's Return on Invested Capital Overview

Pulled from Benzinga Pro data, AMMO (NASDAQ:POWW) showed a loss in earnings since Q3, totaling $527.40 thousand. Sales, on the other hand, increased by 8.37% to $70.10 million during Q4.

Benzinga

Looking Into Avid Bioservices's Return On Capital Employed

According to Benzinga Pro, during Q4, Avid Bioservices (NASDAQ:CDMO) earned $115.60 million, a 5042.26% increase from the preceding quarter. Avid Bioservices's sales decreased to $31.23 million, a 0.9% change since Q3.

Benzinga

Patterson Companies's Return On Capital Employed Insights

According to Benzinga Pro, during Q4, Patterson Companies (NASDAQ:PDCO) earned $63.40 million, a 12.06% increase from the preceding quarter. Patterson Companies also posted a total of $1.64 billion in sales, a 2.63% increase since Q3.

Benzinga

Bed Bath & Beyond's Return On Capital Employed Insights

Benzinga Pro data, Bed Bath & Beyond (NASDAQ:BBBY) reported Q1 sales of $1.46 billion. Earnings fell to a loss of $357.67 million, resulting in a 124.8% decrease from last quarter.

Benzinga

Codiak BioSciences' Engineered Exosome Candidates Show Early Antitumor Activity

Codiak BioSciences Inc (NASDAQ:CDAK) announced platform-validating clinical data from Phase 1 trials of exoSTING and exoIL-12, and it plans to advance both candidates into Phase 2 trials. In an open-label Phase 1 trial, exoIL-12 demonstrated a differentiating favorable safety and tolerability profile, with no detectable systemic exposure of IL-12 and no treatment-related adverse…

Benzinga

Nemaura Medical: Q4 Earnings Insights

Nemaura Medical (NASDAQ:NMRD) reported its Q4 earnings results on Thursday, June 30, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why U.S. Stocks Are Trading Sharply Lower, Jobless Claims Report And More

U.S. stocks traded lower this morning, with the Dow Jones dropping around 450 points on Thursday.

Benzinga

What 7 Analyst Ratings Have To Say About Comcast

Analysts have provided the following ratings for Comcast (NASDAQ:CMCSA) within the last quarter:

Benzinga

Analyst Ratings for T. Rowe Price Gr

T. Rowe Price Gr (NASDAQ:TROW) has observed the following analyst ratings within the last quarter:

Benzinga

Nvidia, Apple, Microsoft And Others Set To Lose As Gartner Predicts Demand Softness For Smartphones, PCs In 2022

China's economic slowdown and inflation-led drop in consumer spending will likely weigh on the global shipments of computers and smartphones in 2022, as per a Reuters story citing research firm Gartner. Earlier this month, Advanced Micro Devices, Inc (NASDAQ:AMD) warned against a slowdown in the PC market after two solid years. Analysts expected the chipmaker to gain…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

NeuroSense Shares Surge On Encouraging Data From Alzheimer's-Associated Biomarker Study

NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has announced results from a biomarker study to evaluate the potential of CogniC, a combination drug for Alzheimer's disease (AD). Earlier this week, NeuroSense reported results from a stage III ALS Biomarker study evaluating PrimeC. Preliminary results showed that levels of disease-related biomarkers in people with ALS were unchanged, in contrast…

Benzinga

The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

3 Stocks Under $2 Insiders Are Aggressively Buying

U.S. stock futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or…

Benzinga

Walgreens Posts Fall In Q3 Profit On Opioid Settlement, Lower Pharmacy Sales

Walgreens Boots Alliance Inc's (NASDAQ:WBA) Q3 FY22 sales decreased 4.2% Y/Y to $32.6 billion, down 2.8% on a constant currency basis, beating the consensus of $32.06 billion. Adjusted EPS reached $0.96, beating the consensus of $0.92, down 28.9% on a constant currency basis against 93.6% growth a year ago that reflected peak…

WEKU

It's been a vicious 6 months for stocks. Here's what the grim markets are signaling

All that whipsawing on Wall Street in the first half of the year reflects real nervousness. Investors are worried the Fed may tip the economy into a recession.

Benzinga

3 Stocks Insiders Are Buying: Children's Place And More

Although US stocks closed mixed on Wednesday, there were a few notable insider trades.

Benzinga

Benzinga Before The Bell: Texas Giga Tesla's Output Ramp Up, California's Lithium Tax, Spot Bitcoin ETF Proposal Rejection And Other Top Financial Stories Thursday, June 30

Reuters Hyundai, Affiliates Plan To Set Up New Company In US:

1 … 312 313 314 315

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Amyotrophic lateral sclerosis

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.